British Biotechnology research and development company BioWarn LLC has unveiled its SmartSense biological substance detection system which can instantly detect the presence of the H5N1 bird flu virus.
SmartSense, which also detects HIV, tuberculosis, MRSA, E.coli, anthrax and smallpox, among others, works by capturing the electronic signature of a virus or biological agent, which it then instantly recognises. Once SmartSense has identified the presence of a virus, those operating the system are alerted.
According to the company’s chief executive officer and board chairman, Dr James P Wade Jr, by using SmartSense an outbreak of human avian flu can be detected and isolated in its early stages so that prevention, vaccines, and treatment can immediately be administered.